OBJECTIVE: : This study aimed to assess national rates, types, and routes of inpatient surgery for pelvic organ prolapse in the United States in 1998 compared to those in 2007. METHODS: : We used the 1998 and 2007 Nationwide Inpatient Sample, which represents a stratified, random sample of discharge data from US hospitals. We included women 20 years and older who underwent surgery for prolapse based on diagnosis and procedure codes of the International Classification of Disease, 9th Revision, Clinical Modification. We calculated the number of women undergoing surgery each year and incidence rates. RESULTS: : The total number of women undergoing prolapse surgeries was 92,503 in 1998 versus 113,646 in 2007. The incidence rate of surgery increased slightly, from 90.8 to 100.9 per 100,000 women, respectively. The most common procedure was hysterectomy, representing approximately half of prolapse surgeries in 1998 and 2007. Suspension procedures accounted for 18.8% of procedures in 2007, an increase from 6.1% in 1998. Surgeries performed via a minimally invasive route increased from 4.8% in 1998 to 9.4% in 2007. However, it was difficult to determine the route for many procedures based on current ICD-9 codes. There were also no codes that specifically designated mesh kit procedures or minimally invasive sacrocolpopexies. CONCLUSIONS: : During the last decade, the rate of inpatient prolapse surgery has slightly increased. The proportion of suspension procedures has increased; however, it is difficult to determine the route of these procedures based on current ICD-9 codes. These findings emphasize that ICD-9 procedure codes have not kept up with changes in clinical practice.
OBJECTIVE: : This study aimed to assess national rates, types, and routes of inpatient surgery for pelvic organ prolapse in the United States in 1998 compared to those in 2007. METHODS: : We used the 1998 and 2007 Nationwide Inpatient Sample, which represents a stratified, random sample of discharge data from US hospitals. We included women 20 years and older who underwent surgery for prolapse based on diagnosis and procedure codes of the International Classification of Disease, 9th Revision, Clinical Modification. We calculated the number of women undergoing surgery each year and incidence rates. RESULTS: : The total number of women undergoing prolapse surgeries was 92,503 in 1998 versus 113,646 in 2007. The incidence rate of surgery increased slightly, from 90.8 to 100.9 per 100,000 women, respectively. The most common procedure was hysterectomy, representing approximately half of prolapse surgeries in 1998 and 2007. Suspension procedures accounted for 18.8% of procedures in 2007, an increase from 6.1% in 1998. Surgeries performed via a minimally invasive route increased from 4.8% in 1998 to 9.4% in 2007. However, it was difficult to determine the route for many procedures based on current ICD-9 codes. There were also no codes that specifically designated mesh kit procedures or minimally invasive sacrocolpopexies. CONCLUSIONS: : During the last decade, the rate of inpatient prolapse surgery has slightly increased. The proportion of suspension procedures has increased; however, it is difficult to determine the route of these procedures based on current ICD-9 codes. These findings emphasize that ICD-9 procedure codes have not kept up with changes in clinical practice.
Authors: Ingrid Nygaard; Matthew D Barber; Kathryn L Burgio; Kimberly Kenton; Susan Meikle; Joseph Schaffer; Cathie Spino; William E Whitehead; Jennifer Wu; Debra J Brody Journal: JAMA Date: 2008-09-17 Impact factor: 56.272
Authors: Bela I Kudish; Cheryl B Iglesia; Robert J Sokol; Barbara Cochrane; Holly E Richter; Joseph Larson; Susan L Hendrix; Barbara V Howard Journal: Obstet Gynecol Date: 2009-01 Impact factor: 7.661
Authors: Teresa Mascarenhas; Miguel Mascarenhas-Saraiva; Amélia Ricon-Ferraz; Paula Nogueira; Fernando Lopes; Alberto Freitas Journal: Int Urogynecol J Date: 2014-08-16 Impact factor: 2.894
Authors: Holly E Richter; Sarah L Morgan; Jonathan L Gleason; Jeff M Szychowski; Patricia S Goode; Kathryn L Burgio Journal: Int Urogynecol J Date: 2013-02-07 Impact factor: 2.894
Authors: Michele Jonsson Funk; Autumn L Edenfield; Virginia Pate; Anthony G Visco; Alison C Weidner; Jennifer M Wu Journal: Am J Obstet Gynecol Date: 2012-11-15 Impact factor: 8.661
Authors: Heidi S Harvie; Amanda A Honeycutt; Simon J Neuwahl; Matthew D Barber; Holly E Richter; Anthony G Visco; Vivian W Sung; Jonathan P Shepherd; Rebecca G Rogers; Sharon Jakus-Waldman; Donna Mazloomdoost Journal: Am J Obstet Gynecol Date: 2018-11-22 Impact factor: 10.693